Medpage Today on MSN13 天
Defining Treatment Success in Chronic Spontaneous Urticaria
With unfortunately no curative therapy for chronic spontaneous urticaria (CSU) available for now, the overall goal is to ...
Medpage Today on MSN13 天
For Your Patients: How Well Is Your Hives Treatment Working?
Is it working? Are your symptoms improving, staying the same, or getting worse? You may be asked to fill out a couple of ...
Jasper Therapeutics: Briquilimab's Potential In Chronic Urticaria And Asthma
Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...
Medscape22 小时
Dupilumab Beneficial When Antihistamines Fall Short for Chronic Spontaneous Urticaria
Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...
Medscape1 天
FDA Considers New Dupilumab Data for Chronic Spontaneous Urticaria Indication
The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...
MedPage Today8 天
Chronic Inflammatory Dermatoses Weight Heavily on Quality of Life—Very Heavily
1 While second-generation H1-antihistamines are standard therapy for both acute and chronic urticaria, some patients need additional treatment to find relief. A new study investigates whether ...
Monthly Prescribing Reference4 天
FDA to Review Resubmitted Dupilumab sBLA for Chronic Spontaneous Urticaria
The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.